ARK Genomic Revolution ETF Rating $24.02 +0.41 (+1.74%) As of 11:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.71Holdings in ARKG have an aggregate rating of Moderate Buy based on 395 analyst ratings issued in the past year covering 32 companies (99.9% of the portfolio).ARKG Aggregate Price Target$23.910.05% UpsideHigh Prediction$23.91Average Prediction$23.91Low Prediction$23.91Holdings in ARKG have an aggregate price target of $23.91 and a range of $23.91 to $23.91 covering 32 companies (99.9% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.61%TEMTempus AI$70.67-1.8%1.6804 of 5 stars2.54$63.42 -10.3%13Gap Up8.36%CRSPCRISPR Therapeutics$44.74+7.6%3.3123 of 5 stars2.47$69.53 55.4%17Gap Up7.14%TWSTTwist Bioscience$34.45-1.7%4.1225 of 5 stars2.70$50.40 46.3%106.11%GHGuardant Health$48.73-1.2%3.7717 of 5 stars3.00$53.76 10.3%21Insider Trade5.82%NTRANatera$165.86-1.4%1.1792 of 5 stars3.00$184.63 11.3%15Positive News5.50%RXRXRecursion Pharmaceuticals$4.98-0.5%1.9129 of 5 stars2.33$7.00 40.7%6Analyst Forecast4.57%SDGRSchrödinger$21.08-0.6%2.5014 of 5 stars3.00$32.80 55.6%64.31%ADPTAdaptive Biotechnologies$10.290.0%2.4029 of 5 stars2.83$9.83 -4.4%63.85%CDNACareDx$19.20+0.7%3.6591 of 5 stars2.67$30.33 58.0%63.70%PSNLPersonalis$6.50+0.8%3.8454 of 5 stars3.00$7.67 17.9%63.42%BEAMBeam Therapeutics$17.60+5.9%3.2674 of 5 stars3.00$48.75 177.1%15Positive NewsGap Up3.42%VCYTVeracyte$26.27-1.4%4.1017 of 5 stars2.70$40.90 55.7%10Analyst Upgrade3.37%TXG10x Genomics$10.84-1.6%4.2398 of 5 stars2.38$15.81 45.9%163.30%IONSIonis Pharmaceuticals$35.49+0.7%4.3969 of 5 stars2.68$57.59 62.3%192.85%ABSIAbsci$2.78-1.6%2.094 of 5 stars3.00$8.40 202.7%5News Coverage2.36%ILMNIllumina$90.14-0.1%4.8762 of 5 stars2.47$126.94 40.8%19Positive News2.36%ARCTArcturus Therapeutics$12.88+0.1%3.2363 of 5 stars3.11$53.50 315.4%9Positive News2.27%NTLAIntellia Therapeutics$10.00+11.6%4.59 of 5 stars2.67$34.95 249.5%21Analyst ForecastGap UpHigh Trading Volume2.05%NRIXNurix Therapeutics$11.65-2.2%1.4644 of 5 stars2.83$30.18 159.1%181.79%AMGNAmgen$294.53-0.4%4.4626 of 5 stars2.38$309.22 5.0%24Positive News1.69%MASS908 Devices$7.34+2.1%1.9936 of 5 stars2.50$5.33 -27.4%4Positive News1.59%BFLYButterfly Network$2.27-1.9%1.7734 of 5 stars3.00$4.00 76.6%21.49%VEEVVeeva Systems$281.91-0.9%3.7728 of 5 stars2.52$269.80 -4.3%25Positive News1.44%QSIQuantum-Si$1.73-2.5%2.5167 of 5 stars2.67$3.48 101.4%31.19%PACBPacific Biosciences of California$1.33-4.0%2.0603 of 5 stars2.50$2.13 60.8%81.15%VRTXVertex Pharmaceuticals$448.49-0.5%4.6372 of 5 stars2.55$513.45 14.5%29Positive News1.08%INCYIncyte$70.02-1.7%4.4899 of 5 stars2.22$74.53 6.4%18Trending NewsAnalyst Upgrade0.99%CERSCerus$1.37-3.2%2.3252 of 5 stars3.00$3.50 156.4%2Positive News0.77%CMPSCOMPASS Pathways$4.79+3.3%2.5076 of 5 stars3.00$18.83 292.9%6Positive NewsGap Up0.66%REGNRegeneron Pharmaceuticals$520.88-0.3%4.8805 of 5 stars2.85$836.48 60.6%26Positive NewsAnalyst Revision0.36%LABStandard BioTools$1.08-2.3%2.7017 of 5 stars2.50$2.50 132.6%2Positive News0.30%PRMEPrime Medicine$1.72+14.4%3.9059 of 5 stars2.75$10.08 487.6%8Positive NewsGap UpHigh Trading Volume This page (BATS:ARKG) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARKG Stock Free ARKG Stock Alerts